Determination of residual pharmaceuticals in edible animal tissues by continuous solid-phase extraction and gas chromatography-mass spectrometry

Department of Physical and Analytical Chemistry, E.P.S of Linares, University of Jaén, 23700 Linares, Jaén, Spain.
Talanta (Impact Factor: 3.55). 05/2011; 84(3):820-8. DOI: 10.1016/j.talanta.2011.02.016
Source: PubMed


A sensitive, reliable method using continuous solid-phase extraction and gas chromatography-mass spectrometry was developed for the simultaneous determination of twenty pharmaceuticals including antibacterials, anti-epileptics, antiseptics, β-blockers, lipid regulators, hormones and non-steroidal anti-inflammatories at trace levels in edible animal tissues. The procedure involves deproteination and delipidation of samples by precipitation/centrifugation/filtration, followed by sample enrichment and cleanup by continuous solid-phase extraction. The proposed method was validated with quite good analytical results including low limits of detections (0.4-2.7 ng kg(-1) for 2g of sample) and good linearity (r(2)>0.995) throughout the studied concentration ranges. In addition, the method is quite accurate (recoveries ranged from 92 to 101%) and precise (within-day and between-day RSD values were less than 7%), which allows the determination of residual pharmaceuticals in tissues from agricultural farm and fish hatchery animals (pig, veal, lamb and chicken muscle, kidney and liver; and salmon, sea bass and sole flesh). The analytes most frequently found in the studied samples were the hormones estrone and 17β-estradiol, and the antibacterials florfenicol and pyrimethamine.

Download full-text


Available from: Evaristo Ballesteros, Feb 28, 2015
  • Source
    • "However, the number of papers published reporting the occurrence and levels of PhACs in marine organisms is considerably lower. They have been performed mainly in mollusks (Wille et al., 2011; McEneff et al., 2014; Klosterhaus et al., 2013; Martinez Bueno et al., 2013, 2014; Li et al., 2012; Dodder et al., 2014) and freshwater fish (Gelsleichter and Szabo, 2013; Maruya et al., 2012; Azzouz et al., 2011). The levels found are usually in the low ng/g (i.e. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The ocurrence and levels of PhACs, Endocrine Disrupting and related Compounds (EDCs) in seafood from potential contaminated areas in Europe has been studied. Macroalgae (Saccharina latissima and Laminaria digitata), bivalves (Mytilus galloprovincialis, Mytilus spp., Chamalea gallina and Crassostrea gigas) and fish (Liza aurata and Platichthys flesus) from Portugal, Spain, Italy, Netherlands, and Norway were analysed following 4 different analytical protocols depending on the organism and target group of contaminants. The results revealed the presence of 4 pharmaceutical compounds in macroalgae samples, 16 in bivalves and 10 in fish. To the best of our knowledge, this is the first time that PhACs have been detected in marine fish and in macroalgae. Besides, this is also the first time that dimetridazole, hydrochlorothiazide and tamsulosin have been detected in biota samples. The highest levels of PhACs corresponded to the psychiatric drug velanfaxine (up to 36.1ng/g dry weight (dw)) and the antibiotic azithromycin (up to 13.3ng/g dw) in bivalves from the Po delta (Italy). EDCs were not detected in macroalgae samples, however, the analysis revealed the presence of 10 EDCs in bivalves and 8 in fish. The highest levels corresponded to the organophosphorus flame retardant tris(2-butoxyethyl)phosphate (TBEP) reaching up to 98.4ng/g dw in mullet fish from the Tagus estuary. Bivalves, in particular mussels, have shown to be good bioindicator organisms for PhACs and fish for EDCs. Taking into consideration the concentrations and frequencies of detection of PhACs and EDCs in the seafood samples analysed, a list of candidates' compounds for priorization in future studies has been proposed.
    Environmental Research 09/2015; 143. DOI:10.1016/j.envres.2015.09.018 · 4.37 Impact Factor
  • Source
    • "Epoxiconazole analysis in environmental samples is extensively documented, but a new method had to be developed for sample preparation. The proposed procedure is mostly based on the Azzouz et al. (2011), Anastassiades et al. (2003), and Hong et al. (2004) ones, respectively for extraction , liquid phase partitioning, and purification steps. Frozen earthworms were individually homogenized using a FastPrep®-24 (MP Biomedicals) in 2 mL of water in a 15-mL polypropylene tube (Falcon BD) with ceramic spheres. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Earthworms play a key role in agroecosystem soil processes. This study aims to assess the effects of different doses of a commercial formulation of epoxiconazole (Opus®), a persistent and widely used fungicide, on the earthworm Aporrectodea icterica. A laboratory study was conducted in a natural soil in order to measure effects of Opus® on earthworm mortality, uptake, weight gain, enzymatic activities (catalase and glutathione-S-transferase), and energy resources (lipids and glycogens). The estimated LC50 was 45.5 mg kg(-1), or 268 times the recommended dose. Weight gains were 28, 19, and 13 % of the initial weight after 28 days of exposure in the control and D1 and D10 (1 and 10 times the recommended dose) treatments, respectively. No difference was observed for catalase activity between the three treatments, at 7, 14, or 28 days. The glutathion-S-transferase (GST) activity was two times as high in D1 as in D0 at 14 days. At 28 days, glycogen concentration was lower in D10 than in the D1 treatment. This study highlighted moderate sublethal effects of the commercial formulation Opus® for earthworms. Considering that these effects were observed on a species found in cultivated fields, even at recommended rates, much more attention should be paid to this pesticide.
    Environmental Science and Pollution Research 06/2015; DOI:10.1007/s11356-015-4845-4 · 2.83 Impact Factor
  • Source
    • "Measurable residues of these compounds may remain behind in animal products if drug withdrawal periods are inadequate or are not observed or if drugs are used in a manner that is inconsistent with their labeling. Numerous studies have developed sensitive methods to detect antimicrobial residues (Berrada et al., 2008; Azzouz et al., 2011; Du et al., 2012; Lehotay et al., 2013). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Pharmaceutical drugs are extensively used in industrial food animal production. We examined whether residues of veterinary antibiotics and other pharmaceuticals and personal care products (PPCPs) were detectable in a small market-basket sample of retail chicken (n = 39), ground beef (n = 3) and milk (n = 3) samples. High-performance liquid chromatography and tandem mass spectrometry were used to assess the concentration of 59 PPCPs and their residues in animal products. All samples of ground beef, milk, and 14 chickens were analyzed individually, while an additional 25 chicken samples were pooled and analyzed in groups of five. The majority of PPCPs were not detected in meat and milk samples. Caffeine was detected in two of three milk samples (0.4 ng/mL, 2.0 ng/mL) and in 10 of 19 individual and pooled chicken samples (median: 18.6 ng/g, range: 6.1–28.8 ng/g). Acetaminophen was detected in three of three milk samples (median: 1.5 ng/mL, range: 1.4–2.1 ng/mL). Antibiotics in the tetracycline class were detected in two of three milk samples (median: 1.0 ng/mL, range: 0.1–2.0 ng/mL) and did not exceed regulatory residue tolerances of 300 ng/mL. There are no regulatory residue tolerances for caffeine or acetaminophen in animal products. The acetaminophen detections in milk, however, raise questions about extra-label and unapproved use of pharmaceutical drugs in food animal production, as this drug is not approved for use in lactating dairy cattle or any other type of food animal production. Additional studies are needed to confirm our finding of PPCPs in meat and dairy products.
    Science of The Total Environment 01/2014; 490:296–300. · 4.10 Impact Factor
Show more